Pregabalin Capsule
Product Images NDC 80425-0170

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1

FDA Label Image

Figure 10

FDA Label Image

Figure 11

FDA Label Image

Figure 12

FDA Label Image

Figure 2

FDA Label Image

Figure 3

FDA Label Image

Figure 4

Figure 4
This appears to be a chart showing the percentage of patients who had improved pain levels based on different dosages of Pregabalin and a placebo. It is not possible to determine more details from the text provided.*
FDA Label Image

Figure 5

FDA Label Image

Figure 6

FDA Label Image

Figure 7

FDA Label Image

Figure 9

Figure 9
The graph displays the percentage of patients who experienced an improvement in pain compared to the baseline. The graph shows four different daily doses, with the highest being 600mg of Pregabalin per day and a placebo. The X-axis displays the values from 210 to 290, while the Y-axis displays percent improvement from baseline pain.*
FDA Label Image

Pregabalin 100mg Cap Qty 90 80425 0170

FDA Label Image

Structure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.